The patent protects both the silver coating developed by the company for medical implants, as well as the method and apparatuses for the production of the coating.
The company has been granted a patent for its silver coating technology by the U.S. Patent and Trademark Office, and it has been granted further European patents for its LOQTEQ and magnesium technology.
More articles on devices:
Bacterin’s Q1 total net revenue up again — 5 key takeaways
NuVasive shares’ mean target price set at $54
Bacterin, Zimmer, SpineGuard & more — 19 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.